Exact Mass: 428.2621

Irbesartan

C25H28N6O (428.2324)

Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

Primolut depot

C27H40O4 (428.2926)

CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10390; ORIGINAL_PRECURSOR_SCAN_NO 10389 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10271; ORIGINAL_PRECURSOR_SCAN_NO 10269 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10375; ORIGINAL_PRECURSOR_SCAN_NO 10374 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10383; ORIGINAL_PRECURSOR_SCAN_NO 10381 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10318; ORIGINAL_PRECURSOR_SCAN_NO 10317 CONFIDENCE standard compound; INTERNAL_ID 655; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10339; ORIGINAL_PRECURSOR_SCAN_NO 10337 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

Nummularine F

C23H32N4O4 (428.2423)

4,4-Diapolycopenedial

C30H36O2 (428.2715)

12-epi-Scalaradial

C27H40O4 (428.2926)

Nonaethylene glycol monomethyl ether

C19H40O10 (428.2621)

25-Hydroxyvitamin D3-26,23-lactone

C27H40O4 (428.2926)

This compound belongs to the family of Sesterterpene Lactones. These are sesterterpenes containing a lactone ring

2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one

C26H36O5 (428.2563)

2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.

Spirostane-3,6-dione

C27H40O4 (428.2926)

Spirostane-3,6-dione is found in fruits. Spirostane-3,6-dione is isolated from fruits of Solanum torvum (pea eggplant). Isolated from fruits of Solanum torvum (pea eggplant). Spirostane-3,6-dione is found in fruits.

Schidigeragenin B

C27H40O4 (428.2926)

Schidigeragenin B is found in fruits. Genin from Yucca schidigera (Mojave yucca

[(8R,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate

C27H40O4 (428.2926)

Calcifediol lactone

C27H40O4 (428.2926)

Lotrafiban

C23H32N4O4 (428.2423)

MG(PGF2alpha/0:0/0:0)

C23H40O7 (428.2774)

MG(PGF2alpha/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(PGE1/0:0/0:0)

C23H40O7 (428.2774)

MG(PGE1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(PGD1/0:0/0:0)

C23H40O7 (428.2774)

MG(PGD1/0:0/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGF2alpha/0:0)

C23H40O7 (428.2774)

MG(0:0/PGF2alpha/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGE1/0:0)

C23H40O7 (428.2774)

MG(0:0/PGE1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

MG(0:0/PGD1/0:0)

C23H40O7 (428.2774)

MG(0:0/PGD1/0:0) is an oxidized monoacyglycerol (MG). Oxidized monoacyglycerols are glycerolipids in which the fatty acyl chain has undergone oxidation. As all oxidized lipids, oxidized monoacyglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with other lipids, monoacyglycerols can be substituted by different fatty acids, with varying lengths, saturation and degrees of oxidation attached at the C-1, C-2 and C-3 positions. Lipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with lipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized lipids is continually in flux, owing to lipid degradation and the continuous lipid remodeling that occurs while these molecules are in membranes. Oxidized MGs can be synthesized via three different routes. In one route, the oxidized MG is synthetized de novo following the same mechanisms as for MGs but incorporating an oxidized acyl chain (PMID: 33329396). An alternative is the transacylation of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the MG backbone, mainly through the action of LOX (PMID: 33329396).

JOKBBQPBIIZMJV-UHFFFAOYSA-N

C26H36O5 (428.2563)

Ingenol-3,4,5,20-diacetonide is a natural compound.

3-Oxo-21α-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone

C27H40O4 (428.2926)

Neoruscogenin

C27H40O4 (428.2926)

Neoruscogenin is a natural product found in Helleborus orientalis with data available. Neoruscogenin, a member of the steroidal sapogenin family, is a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1)[1]. Neoruscogenin, a member of the steroidal sapogenin family, is a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1)[1].

Andrastin D

C26H36O5 (428.2563)

A 3-oxo steroid that is andrastin C in which the acetoxy group at the 3beta position has undergone formal oxidative cleavage to afford the corresponding 3-oxo derivative. A farnesyltransferase inhibitor produced by Penicillium roqueforti, a filamentous fungus involved in the ripening of several kinds of blue cheeses. CONFIDENCE Penicillium bissettii

Dendronpholide I

C22H36O8 (428.241)

Garcinielliptone HB

C26H36O5 (428.2563)

Furoscalarol

C27H40O4 (428.2926)

Kuguacin P

C27H40O4 (428.2926)

Hecogenone

C27H40O4 (428.2926)

Chabrolohydroxybenzoquinone F

C27H40O4 (428.2926)

Sargachromanol I

C27H40O4 (428.2926)

CHEMBL221393

C27H40O4 (428.2926)

Graviphane

C26H36O5 (428.2563)

Kuguacin D

C27H40O4 (428.2926)

Schisanterpene B

C27H40O4 (428.2926)

Strongylophorin 8

C26H36O5 (428.2563)

Scalarafuran

C27H40O4 (428.2926)

Isoscalarafuran A

C27H40O4 (428.2926)

Suberitenone C

C27H40O4 (428.2926)

Rhodomollein XI

C22H36O8 (428.241)

13-(6-hydroxy-2,8-dimethyl-3,4-dihydrochromen-2-yl)-2,6,10-trimethyltrideca-2,6,10-triene-4,5-diol

C27H40O4 (428.2926)

Sargachromanol H

C27H40O4 (428.2926)

Rhodomollein XVI

C22H36O8 (428.241)

Dendronpholide J

C22H36O8 (428.241)

Fallahydroquinone

C27H40O4 (428.2926)

Mooloolaldehyde

C27H40O4 (428.2926)

Comnostin A

C27H40O4 (428.2926)

Palauimide

C25H36N2O4 (428.2675)

25,26,27-Trinor-3,7-dioxolanost-8-en-24-oic acid

C27H40O4 (428.2926)

Prostaglandin F2alpha-1-glyceryl ester

C23H40O7 (428.2774)

Sarga tetraol

C27H40O4 (428.2926)

Maurapyrone B

C26H36O5 (428.2563)

Tamusgenin

C27H40O4 (428.2926)

Demethylstriatol|Mono-norstriatol

C27H40O4 (428.2926)

7-Keto-diosgenin

C27H40O4 (428.2926)

Vilasinin

C26H36O5 (428.2563)

(2E,6E)-2-(10(S),11(S)-dihydroxygeranylgeranyl)-6-methyl-1,4-benzoquinone

C27H40O4 (428.2926)

17,18-Dihydro,17-hydroxy-(2,4,6-Trihydroxyphenyl)-5,8,11,14,17-eicosapentaen-1-one,9CI|2-(17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl)-1,3,5-trihydroxybenzene|2-[17-hydroxy-1-oxo-dodeca-5,8,11,14(all Z)-tetraenyl]-1,3,5-trihydroxybenzene

C26H36O5 (428.2563)

3,6-Dihydroxy-2-(15-phenylpentadecanoyl)-2-cyclohexen-1-one

C27H40O4 (428.2926)

17-Hydroxy-2-(5-Hydoxy-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraenyl)-6-methyl-1,2-benzendiol|2-((2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinone|2-<(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinone|2-[(2E,6E,10E,14Z)-5-hydroxy-15-hydroxymethyl-3,7,11-trimethylhexadeca-2,6,10,14-tetraenyl]-6-methylhydroquinone

C27H40O4 (428.2926)

spirosta-5,25(27)-dien-1,3-diol

C27H40O4 (428.2926)

kadnanolactone E

C27H40O4 (428.2926)

Stypotriol

C27H40O4 (428.2926)

(25R)-3beta-Hydroxy-5alpha-spirost-9(11)-en-12-on|(25R)-3beta-hydroxy-5alpha-spirost-9(11)-en-12-one|3beta-hydroxy-9(11)-en-12-oxo-(25R)-5alpha-spirostane|9(11)-dehydrohecogenin|9-dehydrohecogenin|Delta9(11)-22-isoallospirosten-3beta-ol-12-one|Delta9(11)-hecogenin

C27H40O4 (428.2926)

Lyoniol D|Lyoniol-D

C22H36O8 (428.241)

scalarolide acetate

C27H40O4 (428.2926)

(25R)-17-Hydroxy-spirost-4-en-3-on|(25R)-17-hydroxy-spirost-4-en-3-one|(25R)-17alpha-hydroxyspirost-4-en-3-one|diosbulbisin A

C27H40O4 (428.2926)

methyl-3alpha-angeloyloxypolyalthoate

C26H36O5 (428.2563)

Tricoccin S13

C26H36O5 (428.2563)

4-O-methyl valdivone A

C26H36O5 (428.2563)

12alpha-(2-methylbutyryloxy)-strictic acid methyl ester|12alpha-<2-methylbutyryloxy>-strictic acid methyl ester

C26H36O5 (428.2563)

Ingenol-3,4:5,20-diacetonide

C26H36O5 (428.2563)

Furospongin 4

C26H36O5 (428.2563)

deoxyscalarin

C27H40O4 (428.2926)

Echinoclathrine C

C25H36N2O2S (428.2497)

C27H40O4

C27H40O4 (428.2926)

12-deacetoxyscalarin 19-acetate

C27H40O4 (428.2926)

3-O-methylfuranovibsanin A

C26H36O5 (428.2563)

capilloquinone

C27H40O4 (428.2926)

Litophytolide A

C27H40O4 (428.2926)

Plastoquinone C2

C27H40O4 (428.2926)

4-hydroxy-3-(((1R,4aR,5S,6S,8aR)-6-hydroxy-5,8a-dimethyl-2-methylene-5-(4-methylpent-3-enyl)-decahydronaphthalen-1-yl)-methyl)-5,6-dimethyl-2H-pyran-2-one|BR-050

C27H40O4 (428.2926)

2-((2E,6E)-5-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl)-6-methylhydroquinol|2-<(2E,6E)-5-hydroxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,14-trienyl>-6-methylhydroquinol

C27H40O4 (428.2926)

Methyl(20S,22E)-3beta-acetoxychol-5,22-dienat

C27H40O4 (428.2926)

3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-(alpha-xylopyranoside-2-O-acetate)|3alpha-hydroxy-11-hydroxy-iso-iphionan-4-one-

C22H36O8 (428.241)

salmahyrtisol A

C27H40O4 (428.2926)

(5alpha,12beta,17beta)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-2-methyl-5-oxo-2,5-dihydrofuran-2-yl]gonan-3-one|cylindrictone B

C27H40O4 (428.2926)

19-O-Angeloylhautriwasaeure-methylester

C26H36O5 (428.2563)

(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-butanoate, 20-acetate

C26H36O5 (428.2563)

19-acetyl-12-deacetoxy-12-oxo-deoxoscalarin

C27H40O4 (428.2926)

4,4,14-trimethyl-3,7,15-trimethyl-3,7-dioxochol-8-en-24-oic acid|4,4,14-trimethyl-3,7-dioxochol-8-en-24-oic acid|4,4,14alpha-trimethyl-3,7-dioxo-5alpha-chol-8-en-24-oic acid

C27H40O4 (428.2926)

20S,24-epoxy-25,26,27-trisnor-24-oxo-3,4-seco-dammar-4(28),22-dien-3-oic acid

C27H40O4 (428.2926)

3-Oxo-21|A-methoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone

C27H40O4 (428.2926)

isofurospongin-4

C26H36O5 (428.2563)

A natural product found in Spongia officinalis.

1alpha-acetoxy-3beta,6,8alpha-trihydroxy-2alpha-methoxy-2beta,14beta-epoxy-[4.2.1.10,301.1,4]-tricyclomeliac-7-oate

C26H36O5 (428.2563)

(2R)-2,8-dimethyl-2-[(3E,7E)-4,8-dimethyl-13-hydroxy-12-hydroxymethyldeca-3,7,11-trienyl]chroman-6-ol|delta-amplexichromanol

C27H40O4 (428.2926)

erythro-23-O-methylneocyclocitrinol|threo-23-O-methylneocyclocitrinol

C27H40O4 (428.2926)

(25R)-spirost-4-en-3-on-2-ol

C27H40O4 (428.2926)

15alpha-hydroxy-3-oxo-5alpha-lanosta-7,9(11)-dien-24-oic acid|ganoderic acid Jd

C27H40O4 (428.2926)

13,14-dihydroxy-15,16 dimethoxy-(-)-6alpha-hydroxy-5alpha,8alpha,9alpha,10alpha-cleroda-3-en-18-oic acid

C22H36O8 (428.241)

2alpha-(4-methylsenecioyloxy)-15,16-epoxylabda-7,13(16),14-trien-18-oic acid|2alpha-<4-methylsenecioyloxy>-15,16-epoxylabda-7,13(16),14-trien-18-oic acid

C26H36O5 (428.2563)

gutierrezianolic acid (angelate) methyl ester|gutierrezianolic acid methyl ester|methyl 6alpha-angeloyloxy-15,16-epoxy-labda-7,13(16),14-trien-17-oate

C26H36O5 (428.2563)

7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-14,20(22)-dien-21,23-olide

C26H36O5 (428.2563)

C26H36O5

C26H36O5 (428.2563)

(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17-acetate, 20-butanoate

C26H36O5 (428.2563)

Botogenin|gentrogenin|hecogenin

C27H40O4 (428.2926)

3beta,11alpha-dihydroxyspirosta-5,25(27)-diene|spirost-5,25(27)-diene-3beta,11alpha-diol

C27H40O4 (428.2926)

Sargatetraol

C27H40O4 (428.2926)

cladobotric acid B

C26H36O5 (428.2563)

Gentrogenin

C27H40O4 (428.2926)

5beta,11-dihydroxy-iphionan-4-one-11-O-(alpha-xylopyranoside-2-O-acetate)|5beta,11-dihydroxy-iphionan-4-one-11-O-

C22H36O8 (428.241)

(16beta,22E)-16,18,20-Trihydroxycholesta-1,4,22-trien-3-one|(20S,22E)-cholesta-1,4,22-triene-16beta,18,20-triol-3-one

C27H40O4 (428.2926)

(+)-dodecanoyllomatin

C26H36O5 (428.2563)

furospongin 4|furospongin-4

C26H36O5 (428.2563)

24-methyl-12,24,25-trioxoscalar-16-en-22-oic acid

C26H36O5 (428.2563)

19-norpregna-1,3,5(10),20-tetraen-3-O-alpha-fucopyranoside

C26H36O5 (428.2563)

Furospongin 3

C26H36O5 (428.2563)

Pycnophorin

C27H40O4 (428.2926)

4,5-dioxo-seco-gamma-eudesmol-(alpha-xylopyranoside-2-O-acetate)|4,5-dioxo-seco-gamma-eudesmol-

C22H36O8 (428.241)

3-Anhydroisonuatigenin

C27H40O4 (428.2926)

(3beta,25R)-3-Hydroxyspirost-5-en-7-one

C27H40O4 (428.2926)

Trp Pro Leu

C23H32N4O4 (428.2423)

Leu Pro Trp

C23H32N4O4 (428.2423)

(25S)-12β-Hydroxyspirost-4-en-3-one

C27H40O4 (428.2926)

irbesartan

C25H28N6O (428.2324)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1074 CONFIDENCE standard compound; INTERNAL_ID 2094 CONFIDENCE standard compound; INTERNAL_ID 8187 Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

Irbesartan (Avapro)

C25H28N6O (428.2324)

Irbesartan. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=138402-11-6 (retrieved 2024-07-09) (CAS RN: 138402-11-6). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

MLS001148643-01!17ALPHA-HYDROXYPROGESTERONE CAPROATE630-56-8

C27H40O4 (428.2926)

C27H40O4_(3beta,5alpha,8xi,14xi,25S)-3-Hydroxyspirost-9(11)-en-12-one

C27H40O4 (428.2926)

9(11)-dehydrohecogenin

C27H40O4 (428.2926)

Origin: Plant, Sapogenins

Ala Lys Asn Pro

C18H32N6O6 (428.2383)

Ala Lys Pro Asn

C18H32N6O6 (428.2383)

Ala Asn Lys Pro

C18H32N6O6 (428.2383)

Ala Asn Pro Lys

C18H32N6O6 (428.2383)

Ala Pro Lys Asn

C18H32N6O6 (428.2383)

Ala Pro Asn Lys

C18H32N6O6 (428.2383)

Gly Lys Lys Pro

C19H36N6O5 (428.2747)

Gly Lys Pro Lys

C19H36N6O5 (428.2747)

Gly Lys Pro Gln

C18H32N6O6 (428.2383)

Gly Lys Gln Pro

C18H32N6O6 (428.2383)

Gly Pro Lys Lys

C19H36N6O5 (428.2747)

Gly Pro Lys Gln

C18H32N6O6 (428.2383)

Gly Pro Gln Lys

C18H32N6O6 (428.2383)

Gly Gln Lys Pro

C18H32N6O6 (428.2383)

Gly Gln Pro Lys

C18H32N6O6 (428.2383)

Ile Ile Pro Ser

C20H36N4O6 (428.2635)

Ile Ile Ser Pro

C20H36N4O6 (428.2635)

Ile Leu Pro Ser

C20H36N4O6 (428.2635)

Ile Leu Ser Pro

C20H36N4O6 (428.2635)

Ile Pro Ile Ser

C20H36N4O6 (428.2635)

Ile Pro Leu Ser

C20H36N4O6 (428.2635)

Ile Pro Ser Ile

C20H36N4O6 (428.2635)

Ile Pro Ser Leu

C20H36N4O6 (428.2635)

Ile Pro Thr Val

C20H36N4O6 (428.2635)

Ile Pro Val Thr

C20H36N4O6 (428.2635)

Ile Ser Ile Pro

C20H36N4O6 (428.2635)

Ile Ser Leu Pro

C20H36N4O6 (428.2635)

Ile Ser Pro Ile

C20H36N4O6 (428.2635)

Ile Ser Pro Leu

C20H36N4O6 (428.2635)

Ile Thr Pro Val

C20H36N4O6 (428.2635)

Ile Thr Val Pro

C20H36N4O6 (428.2635)

Ile Val Pro Thr

C20H36N4O6 (428.2635)

Ile Val Thr Pro

C20H36N4O6 (428.2635)

Lys Ala Asn Pro

C18H32N6O6 (428.2383)

Lys Ala Pro Asn

C18H32N6O6 (428.2383)

Lys Gly Lys Pro

C19H36N6O5 (428.2747)

Lys Gly Pro Lys

C19H36N6O5 (428.2747)

Lys Gly Pro Gln

C18H32N6O6 (428.2383)

Lys Gly Gln Pro

C18H32N6O6 (428.2383)

Lys Lys Gly Pro

C19H36N6O5 (428.2747)

Lys Lys Pro Gly

C19H36N6O5 (428.2747)

Lys Asn Ala Pro

C18H32N6O6 (428.2383)

Lys Asn Pro Ala

C18H32N6O6 (428.2383)

Lys Pro Ala Asn

C18H32N6O6 (428.2383)

Lys Pro Gly Lys

C19H36N6O5 (428.2747)

Lys Pro Gly Gln

C18H32N6O6 (428.2383)

Lys Pro Lys Gly

C19H36N6O5 (428.2747)

Lys Pro Asn Ala

C18H32N6O6 (428.2383)

Lys Pro Gln Gly

C18H32N6O6 (428.2383)

Lys Gln Gly Pro

C18H32N6O6 (428.2383)

Lys Gln Pro Gly

C18H32N6O6 (428.2383)

Leu Ile Pro Ser

C20H36N4O6 (428.2635)

Leu Ile Ser Pro

C20H36N4O6 (428.2635)

Leu Leu Pro Ser

C20H36N4O6 (428.2635)

Leu Leu Ser Pro

C20H36N4O6 (428.2635)

Leu Pro Ile Ser

C20H36N4O6 (428.2635)

Leu Pro Leu Ser

C20H36N4O6 (428.2635)

Leu Pro Ser Ile

C20H36N4O6 (428.2635)

Leu Pro Ser Leu

C20H36N4O6 (428.2635)

Leu Pro Thr Val

C20H36N4O6 (428.2635)

Leu Pro Val Thr

C20H36N4O6 (428.2635)

Leu Ser Ile Pro

C20H36N4O6 (428.2635)

Leu Ser Leu Pro

C20H36N4O6 (428.2635)

Leu Ser Pro Ile

C20H36N4O6 (428.2635)

Leu Ser Pro Leu

C20H36N4O6 (428.2635)

Leu Thr Pro Val

C20H36N4O6 (428.2635)

Leu Thr Val Pro

C20H36N4O6 (428.2635)

Leu Val Pro Thr

C20H36N4O6 (428.2635)

Leu Val Thr Pro

C20H36N4O6 (428.2635)

Asn Ala Lys Pro

C18H32N6O6 (428.2383)

Asn Ala Pro Lys

C18H32N6O6 (428.2383)

Asn Lys Ala Pro

C18H32N6O6 (428.2383)

Asn Lys Pro Ala

C18H32N6O6 (428.2383)

Asn Pro Ala Lys

C18H32N6O6 (428.2383)

Asn Pro Lys Ala

C18H32N6O6 (428.2383)

Pro Ala Lys Asn

C18H32N6O6 (428.2383)

Pro Ala Asn Lys

C18H32N6O6 (428.2383)

Pro Gly Lys Lys

C19H36N6O5 (428.2747)

Pro Gly Lys Gln

C18H32N6O6 (428.2383)

Pro Gly Gln Lys

C18H32N6O6 (428.2383)

Pro Ile Ile Ser

C20H36N4O6 (428.2635)

Pro Ile Leu Ser

C20H36N4O6 (428.2635)

Pro Ile Ser Ile

C20H36N4O6 (428.2635)

Pro Ile Ser Leu

C20H36N4O6 (428.2635)

Pro Ile Thr Val

C20H36N4O6 (428.2635)

Pro Ile Val Thr

C20H36N4O6 (428.2635)

Pro Lys Ala Asn

C18H32N6O6 (428.2383)

Pro Lys Gly Lys

C19H36N6O5 (428.2747)

Pro Lys Gly Gln

C18H32N6O6 (428.2383)

Pro Lys Lys Gly

C19H36N6O5 (428.2747)

Pro Lys Asn Ala

C18H32N6O6 (428.2383)

Pro Lys Gln Gly

C18H32N6O6 (428.2383)

Pro Leu Ile Ser

C20H36N4O6 (428.2635)

Pro Leu Leu Ser

C20H36N4O6 (428.2635)

Pro Leu Ser Ile

C20H36N4O6 (428.2635)

Pro Leu Ser Leu

C20H36N4O6 (428.2635)

Pro Leu Thr Val

C20H36N4O6 (428.2635)

Pro Leu Val Thr

C20H36N4O6 (428.2635)

Pro Asn Ala Lys

C18H32N6O6 (428.2383)

Pro Asn Lys Ala

C18H32N6O6 (428.2383)

Pro Gln Gly Lys

C18H32N6O6 (428.2383)

Pro Gln Lys Gly

C18H32N6O6 (428.2383)

Pro Ser Ile Ile

C20H36N4O6 (428.2635)

Pro Ser Ile Leu

C20H36N4O6 (428.2635)

Pro Ser Leu Ile

C20H36N4O6 (428.2635)

Pro Ser Leu Leu

C20H36N4O6 (428.2635)

Pro Thr Ile Val

C20H36N4O6 (428.2635)

Pro Thr Leu Val

C20H36N4O6 (428.2635)

Pro Thr Val Ile

C20H36N4O6 (428.2635)

Pro Thr Val Leu

C20H36N4O6 (428.2635)

Pro Val Ile Thr

C20H36N4O6 (428.2635)

Pro Val Leu Thr

C20H36N4O6 (428.2635)

Pro Val Thr Ile

C20H36N4O6 (428.2635)

Pro Val Thr Leu

C20H36N4O6 (428.2635)

Gln Gly Lys Pro

C18H32N6O6 (428.2383)

Gln Gly Pro Lys

C18H32N6O6 (428.2383)

Gln Lys Gly Pro

C18H32N6O6 (428.2383)

Gln Lys Pro Gly

C18H32N6O6 (428.2383)

Gln Pro Gly Lys

C18H32N6O6 (428.2383)

Gln Pro Lys Gly

C18H32N6O6 (428.2383)

Ser Ile Ile Pro

C20H36N4O6 (428.2635)

Ser Ile Leu Pro

C20H36N4O6 (428.2635)

Ser Ile Pro Ile

C20H36N4O6 (428.2635)

Ser Ile Pro Leu

C20H36N4O6 (428.2635)

Ser Leu Ile Pro

C20H36N4O6 (428.2635)

Ser Leu Leu Pro

C20H36N4O6 (428.2635)

Ser Leu Pro Ile

C20H36N4O6 (428.2635)

Ser Leu Pro Leu

C20H36N4O6 (428.2635)

Ser Pro Ile Ile

C20H36N4O6 (428.2635)

Ser Pro Ile Leu

C20H36N4O6 (428.2635)

Ser Pro Leu Ile

C20H36N4O6 (428.2635)

Ser Pro Leu Leu

C20H36N4O6 (428.2635)

Thr Ile Pro Val

C20H36N4O6 (428.2635)

Thr Ile Val Pro

C20H36N4O6 (428.2635)

Thr Leu Pro Val

C20H36N4O6 (428.2635)

Thr Leu Val Pro

C20H36N4O6 (428.2635)

Thr Pro Ile Val

C20H36N4O6 (428.2635)

Thr Pro Leu Val

C20H36N4O6 (428.2635)

Thr Pro Val Ile

C20H36N4O6 (428.2635)

Thr Pro Val Leu

C20H36N4O6 (428.2635)

Thr Val Ile Pro

C20H36N4O6 (428.2635)

Thr Val Leu Pro

C20H36N4O6 (428.2635)

Thr Val Pro Ile

C20H36N4O6 (428.2635)

Thr Val Pro Leu

C20H36N4O6 (428.2635)

Val Ile Pro Thr

C20H36N4O6 (428.2635)

Val Ile Thr Pro

C20H36N4O6 (428.2635)

Val Leu Pro Thr

C20H36N4O6 (428.2635)

Val Leu Thr Pro

C20H36N4O6 (428.2635)

Val Pro Ile Thr

C20H36N4O6 (428.2635)

Val Pro Leu Thr

C20H36N4O6 (428.2635)

Val Pro Thr Ile

C20H36N4O6 (428.2635)

Val Pro Thr Leu

C20H36N4O6 (428.2635)

Val Thr Ile Pro

C20H36N4O6 (428.2635)

Val Thr Leu Pro

C20H36N4O6 (428.2635)

Val Thr Pro Ile

C20H36N4O6 (428.2635)

Val Thr Pro Leu

C20H36N4O6 (428.2635)

PGF2alpha-G

C23H40O7 (428.2774)

2-glyceryl-PGF2&alpha

C23H40O7 (428.2774)

(23R,25R)-25-hydroxyvitamin D3 26,23-lactone / (23R,25R)-25-hydroxycholecalciferol 26,23-lactone

C27H40O4 (428.2926)

(23S,25R)-25-hydroxyvitamin D3 26,23-lactone / (23S,25R)-25-hydroxycholecalciferol 26,23-lactone

C27H40O4 (428.2926)

(23R,25S)-25-hydroxyvitamin D3 26,23-lactone / (23R,25S)-25-hydroxycholecalciferol 26,23-lactone

C27H40O4 (428.2926)

(23S,25S)-25-hydroxyvitamin D3 26,23-lactone / (23S,25S)-25-hydroxycholecalciferol 26,23-lactone

C27H40O4 (428.2926)

(5Z,7E,22E)-(1S,3R,24R,25R)-25,26-epoxy-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol

C27H40O4 (428.2926)

(5Z,7E,22E)-(1S,3R,24S,25S)-25,26-epoxy-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,24-triol

C27H40O4 (428.2926)

1,25-Dihydroxy-24-oxo-16-ene-vitamin D3

C27H40O4 (428.2926)

D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

ZK118182 isopropyl ester

C23H37ClO5 (428.2329)

Homostypolhydroperoxide

C27H40O4 (428.2926)

2-Angeloyl-9-(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one

C26H36O5 (428.2563)

Schidigeragenin B

C27H40O4 (428.2926)

Chlorogenone

C27H40O4 (428.2926)

FA 23:3;O5

C23H40O7 (428.2774)

ST 27:4;O4

C27H40O4 (428.2926)

ST 28:3;O4

C27H40O4 (428.2926)

(23S,25R)-25-hydroxyvitamin D3 26,23-lactone

C27H40O4 (428.2926)

(22E)-(24R,25R)-25,26-epoxy-1alpha,24-dihydroxy-22,23-didehydrovitamin D3

C27H40O4 (428.2926)

(22E)-(24S,25S)-25,26-epoxy-1alpha,24-dihydroxy-22,23-didehydrovitamin D3

C27H40O4 (428.2926)

Cuminone H

C27H40O4 (428.2926)

3-Octadecanoylumbelliferone

C27H40O4 (428.2926)

1,4,8,11-Tetrakis(aminocarbonylmethyl)-1,4,8,11-tetraazacyclotetradecane

C18H36N8O4 (428.2859)

Dicirenone

C26H36O5 (428.2563)

C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal

5-(3,5-dimethyl-4-octoxyphenyl)-3-hexylthiophene-2-carbaldehyde

C27H40O2S (428.2749)

Boc-Asp(OMe)-OH·DCHA

C22H40N2O6 (428.2886)

11beta-hydroxy-D-homopregna-1,4-diene-3,20-dione 17a-butyrate

C26H36O5 (428.2563)

HEXOCYCLIUM METHYLSULFATE

C21H36N2O5S (428.2345)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

AZ 6102

C25H28N6O (428.2324)

(3R,4R,5S)-ethyl 4-acetamido-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

C22H37ClN2O4 (428.2442)

EINECS 211-138-8

C27H40O4 (428.2926)

[4-[3-(decyloxy)-2-hydroxypropoxy]-2-hydroxyphenyl] phenyl ketone

C26H36O5 (428.2563)

Umeclidinium

C29H34NO2+ (428.2589)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

Scalaradial

C27H40O4 (428.2926)

A scalarane sesterterpenoid with formula C27H40O4. It is a natural product found in the marine sponges Spongia officinalis and Cacospongia mollior, and exhibits anti-inflammatory activity.

2-Phenyl-1-[4-(2-piperidin-1-YL-ethoxy)-phenyl]-1,2,3,4-tetrahydro-isoquinolin-6-OL

C28H32N2O2 (428.2464)

[(8R,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate

C27H40O4 (428.2926)

prostaglandin F2alpha 1-glyceryl ester

C23H40O7 (428.2774)

A 1-monoglyceride resulting from the condensation of the carboxy group of prostaglandin F2alpha with the 1-hydroxy group of glycerol.

(22E)-(24R,25R)-25,26-epoxy-1alpha,24-dihydroxy-22,23-didehydrovitamin D3/(22E)-(24R,25R)-25,26-epoxy-1alpha,24-dihydroxy-22,23-didehydrocholecalciferol

C27H40O4 (428.2926)

(6R)-6-[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-3-oxoheptanoic acid

C27H40O4 (428.2926)

16-Hydroxy-7,9,13-trimethyl-5-methylidenespiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-10-one

C27H40O4 (428.2926)

MG(PGF2alpha/0:0/0:0)

C23H40O7 (428.2774)

MG(0:0/PGF2alpha/0:0)

C23H40O7 (428.2774)

MG(PGE1/0:0/0:0)

C23H40O7 (428.2774)

MG(PGD1/0:0/0:0)

C23H40O7 (428.2774)

MG(0:0/PGE1/0:0)

C23H40O7 (428.2774)

MG(0:0/PGD1/0:0)

C23H40O7 (428.2774)

3-hydroxy-5-[2-[(4Z)-4-[(2E)-2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]propyl]-3-methyloxolan-2-one

C27H40O4 (428.2926)

Plastoquinone 2

C27H40O4 (428.2926)

A natural product found in Sargassum micracanthum.

Furospongin-4

C26H36O5 (428.2563)

A natural product found in Spongia officinalis.

3-[[cyclopentyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-8-methyl-1H-quinolin-2-one

C25H28N6O (428.2324)

protoaustinoid B

C26H36O5 (428.2563)

chermesin D methyl ester

C26H36O5 (428.2563)

(1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate

C26H36O5 (428.2563)

1-[3-methyl-2-[[2-(methylamino)-1-oxopropyl]amino]-1-oxobutyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2-pyrrolidinecarboxamide

C24H36N4O3 (428.2787)

4-{[(4-Fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium

C25H35FN3O2+ (428.2713)

(1R)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C23H32N4O4 (428.2423)

(1S)-1-(hydroxymethyl)-7-methoxy-2-(1-oxobutyl)-N-propan-2-yl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C23H32N4O4 (428.2423)

(5alpha,8xi,14xi,16xi,17xi)-3-Hydroxyspirost-9(11)-en-12-one

C27H40O4 (428.2926)

Fluoromesityl(2,4,6-tri-tert-butylphenyl)silanol

C27H41FOSi (428.2911)

2,3-Dihydroxypropyl (2-hydroxy-3-tridecoxypropyl) hydrogen phosphate

C19H41O8P (428.2539)

Fahfa 27:6

C27H40O4 (428.2926)

N-Acetyl-alanyl-valyl-leucyl-alanine methyl ester

C20H36N4O6 (428.2635)

hydroxyprogesterone caproate

C27H40O4 (428.2926)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

(all-E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)

Spirostane-3,6-dione

C27H40O4 (428.2926)

25-Hydroxyvitamin D3-26,23-lactone

C27H40O4 (428.2926)

2-glyceryl-Prostaglandin F2alpha

C23H40O7 (428.2774)

17(20)-Dehydrocryptogenin

C27H40O4 (428.2926)

prostaglandin F2alpha 2-glyceryl ester

C23H40O7 (428.2774)

A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin F2alpha with the 2-hydroxy group of glycerol.

Glyceryl-PGF2alpha

C23H40O7 (428.2774)

FAHFA 10:1/O-17:5

C27H40O4 (428.2926)

FAHFA 10:2/O-17:4

C27H40O4 (428.2926)

FAHFA 10:3/O-17:3

C27H40O4 (428.2926)

FAHFA 11:1/O-16:5

C27H40O4 (428.2926)

FAHFA 11:2/O-16:4

C27H40O4 (428.2926)

FAHFA 11:3/O-16:3

C27H40O4 (428.2926)

FAHFA 12:1/O-15:5

C27H40O4 (428.2926)

FAHFA 12:2/O-15:4

C27H40O4 (428.2926)

FAHFA 12:3/O-15:3

C27H40O4 (428.2926)

FAHFA 12:4/O-15:2

C27H40O4 (428.2926)

FAHFA 13:2/O-14:4

C27H40O4 (428.2926)

FAHFA 13:3/O-14:3

C27H40O4 (428.2926)

FAHFA 13:4/O-14:2

C27H40O4 (428.2926)

FAHFA 14:2/O-13:4

C27H40O4 (428.2926)

FAHFA 14:3/O-13:3

C27H40O4 (428.2926)

FAHFA 14:4/O-13:2

C27H40O4 (428.2926)

FAHFA 15:2/O-12:4

C27H40O4 (428.2926)

FAHFA 15:3/O-12:3

C27H40O4 (428.2926)

FAHFA 15:4/O-12:2

C27H40O4 (428.2926)

FAHFA 15:5/O-12:1

C27H40O4 (428.2926)

FAHFA 16:3/O-11:3

C27H40O4 (428.2926)

FAHFA 16:4/O-11:2

C27H40O4 (428.2926)

FAHFA 16:5/O-11:1

C27H40O4 (428.2926)

FAHFA 17:3/O-10:3

C27H40O4 (428.2926)

FAHFA 17:4/O-10:2

C27H40O4 (428.2926)

FAHFA 17:5/O-10:1

C27H40O4 (428.2926)

FAHFA 18:3/O-9:3

C27H40O4 (428.2926)

FAHFA 18:4/O-9:2

C27H40O4 (428.2926)

FAHFA 18:5/O-9:1

C27H40O4 (428.2926)

FAHFA 18:6/O-9:0

C27H40O4 (428.2926)

FAHFA 19:4/O-8:2

C27H40O4 (428.2926)

FAHFA 19:5/O-8:1

C27H40O4 (428.2926)

FAHFA 19:6/O-8:0

C27H40O4 (428.2926)

FAHFA 27:6;O

C27H40O4 (428.2926)

FAHFA 8:0/O-19:6

C27H40O4 (428.2926)

FAHFA 8:1/O-19:5

C27H40O4 (428.2926)

FAHFA 8:2/O-19:4

C27H40O4 (428.2926)

FAHFA 9:0/O-18:6

C27H40O4 (428.2926)

FAHFA 9:1/O-18:5

C27H40O4 (428.2926)

FAHFA 9:2/O-18:4

C27H40O4 (428.2926)

FAHFA 9:3/O-18:3

C27H40O4 (428.2926)

LPG O-13:0

C19H41O8P (428.2539)

ST 23:0;O2;S

C23H40O5S (428.2596)

ST 22:1;O8

C22H36O8 (428.241)

ST 26:5;O5

C26H36O5 (428.2563)

ST 23:0;O7

C23H40O7 (428.2774)

(1s,3as,3br,9ar,9bs,11as)-1-hydroxy-1-[(2r,3r,6r)-2-hydroxy-6-isopropyloxan-3-yl]-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H40O4 (428.2926)

16'-hydroxy-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-11'-en-10'-one

C27H40O4 (428.2926)

1-ethylidene-7-isopropyl-3-[(2-methylbut-2-enoyl)oxy]-4-methylidene-2-oxo-hexahydroinden-5-yl 3-methylpent-2-enoate

C26H36O5 (428.2563)

(2s,3r,4s,5r)-4,5-dihydroxy-2-({2-[(1r,4r)-4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

C22H36O8 (428.241)

13-hydroxy-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-b]furan-4-yl acetate

C27H40O4 (428.2926)

(1's,2r,2's,4's,7's,8'r,9's,12's,13'r,14'r,16'r)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-14',16'-diol

C27H40O4 (428.2926)

(2's,4'ar,4'bs,7's,8'ar)-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthrene]-4,5,7'-triol

C27H40O4 (428.2926)

sargachromanol d

C27H40O4 (428.2926)

methyl (1r,4s,4as,8ar)-1-[2-(furan-3-yl)ethyl]-5,5,8a-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylate

C26H36O5 (428.2563)

2-[(2e,6e,10e,12s)-12-hydroxy-11-(hydroxymethyl)-3,7,15-trimethylhexadeca-2,6,10,14-tetraen-1-yl]-6-methylbenzene-1,4-diol

C27H40O4 (428.2926)

4-hydroxy-3-{[3-(hydroxymethyl)-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl]methyl}benzoic acid

C27H40O4 (428.2926)

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16',19'-dione

C27H40O4 (428.2926)

(4r,5ar,5br,7as,11as,11br,13r,13ar)-13-hydroxy-5b,8,8,11a,13a-pentamethyl-4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-b]furan-4-yl acetate

C27H40O4 (428.2926)

(1r,3r,4ar,5s,8ar)-5-[2-(furan-3-yl)ethyl]-1,4a,6-trimethyl-3-{[(2e)-3-methylpent-2-enoyl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid

C26H36O5 (428.2563)

methyl 1-[2-(furan-3-yl)ethyl]-5,5,8a-trimethyl-4-[(2-methylbut-2-enoyl)oxy]-1,4,4a,6,7,8-hexahydronaphthalene-2-carboxylate

C26H36O5 (428.2563)

2-{[2-(3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)

8-formyl-1-hydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl 2,3-dimethylbutanoate

C26H36O5 (428.2563)

(4r,6r,7z,10e)-4-hydroxy-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-7,10-dien-5-one

C27H40O4 (428.2926)

(4r)-4-hydroxy-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-2,10-dien-5-one

C27H40O4 (428.2926)

(4r,6s,7z,10e)-4-hydroxy-13-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2,6,10-trimethyltrideca-7,10-dien-5-one

C27H40O4 (428.2926)

(1r,3s,4r,6s,7s,8s,9s,10r,13s,14s,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

(4r)-4-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,3h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C27H40O4 (428.2926)

n-[1-(2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl)-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

C25H36N2O4 (428.2675)

(5s)-5-[(3r,8r,10s,11s,12s,15s,16r)-10-hydroxy-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]-5-methyloxolan-2-one

C27H40O4 (428.2926)

2-{1-methoxy-4,8,12,12-tetramethyl-3,13-dioxatetracyclo[6.6.2.0²,⁶.0¹¹,¹⁵]hexadeca-2(6),4-dien-7-yl}ethenyl 3-methylbut-2-enoate

C26H36O5 (428.2563)

n-[(2r)-1-[(2s)-2-benzyl-3-methoxy-4-methyl-5-oxo-2h-pyrrol-1-yl]-3-methyl-1-oxobutan-2-yl]-2-methylhexanimidic acid

C25H36N2O4 (428.2675)

2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaenedial

C30H36O2 (428.2715)

methyl 1-hydroxy-2,3b,6,6,9a,11,11a-heptamethyl-3,7-dioxo-4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-3a-carboxylate

C26H36O5 (428.2563)

17-(furan-3-yl)-6-(methoxycarbonyl)-2,10,14-trimethylheptadeca-2,6,10,14-tetraenoic acid

C26H36O5 (428.2563)

(2s,3r,4s,5r)-2-({2-[(3r,3ar,5r,7as)-3a-acetyl-3-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)

4,5-dihydroxy-2-({2-[4-methyl-3-oxo-4-(4-oxopentyl)cyclohexyl]propan-2-yl}oxy)oxan-3-yl acetate

C22H36O8 (428.241)

7-[2-hydroxy-6-(hydroxymethyl)-3-methyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid

C26H36O5 (428.2563)

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

13-(furan-3-yl)-2-(5-methoxy-4-methyl-5-oxopent-3-en-1-yl)-6,10-dimethyltrideca-2,6,10-trienoic acid

C26H36O5 (428.2563)

(2s)-1-[(2s,5r)-5-[(2r)-1-ethoxy-1-oxopropan-2-yl]oxolan-2-yl]butan-2-yl (2s)-2-[(2s,5r)-5-[(2r)-2-hydroxypropyl]oxolan-2-yl]propanoate

C23H40O7 (428.2774)

methyl 5-[2-(furan-3-yl)ethyl]-1,4a-dimethyl-2-[(2-methylbut-2-enoyl)oxy]-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C26H36O5 (428.2563)

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16s)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)

2-{5-[(acetyloxy)methyl]-11-methyl-14-oxabicyclo[11.2.1]hexadeca-1(15),4,10,13(16)-tetraen-8-yl}prop-2-en-1-yl butanoate

C26H36O5 (428.2563)

5-{10-hydroxy-2,6,15,19-tetramethyl-3,8-dioxatetracyclo[9.8.0.0²,⁷.0¹²,¹⁷]nonadeca-14,18-dien-9-yl}penta-2,4-dienoic acid

C26H36O5 (428.2563)

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

(1r,2s,3r,4r,6s,8s,9r,10r,13r,14r,16r)-2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

(1r,3r,4r,10s,14r,15r,17r,18s)-18-[(acetyloxy)methyl]-17-hydroxy-3-(methoxycarbonyl)-14-methyl-12λ⁵-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icosa-7(20),12(19)-dien-12-ylium

[C25H34NO5]+ (428.2437)

(1s,2s,5s,6s,7r,10r,11s)-6-[(2,5-dihydroxyphenyl)methyl]-5-hydroxy-5,7,11-trimethyl-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-12-one

C26H36O5 (428.2563)

(1s,13r)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

n-[2-hydroxy-6-(2-methylpyridin-4-yl)phenyl]-13-sulfanyltridecanimidic acid

C25H36N2O2S (428.2497)

methyl 3-{[(1r,2s,4as,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-4-(acetyloxy)-5-methoxybenzoate

C26H36O5 (428.2563)

(1r,2r,6r,10s,11r,13s,15r)-8-formyl-1-hydroxy-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl (2r)-2,3-dimethylbutanoate

C26H36O5 (428.2563)

2-[(2s,4r)-4-(6-ethyl-3,5-dimethyl-4-oxopyran-2-yl)-3-oxopentan-2-yl]-3,5-dimethyl-6-pentylpyran-4-one

C26H36O5 (428.2563)

2-[(1s,2r,5r,7s,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)

methyl 5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-8a-{[(2-methylbut-2-enoyl)oxy]methyl}-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate

C26H36O5 (428.2563)

2-[(1s,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)

(1z,3s,3ar,5r,7s,7as)-1-ethylidene-7-isopropyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-4-methylidene-2-oxo-hexahydroinden-5-yl (2e)-3-methylpent-2-enoate

C26H36O5 (428.2563)

(7z)-7-(1-hydroxy-2-methylpropylidene)-2-(2-methoxypropan-2-yl)-5,5-bis(3-methylbut-2-en-1-yl)-1-benzofuran-4,6-dione

C26H36O5 (428.2563)

methyl (1e,3z,6s,7r)-6-[(2r)-2-(furan-3-yl)-2-{[(2r)-2-methylbutanoyl]oxy}ethyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylate

C26H36O5 (428.2563)

2-[4-(6-ethyl-3,5-dimethyl-4-oxopyran-2-yl)-3-oxopentan-2-yl]-3,5-dimethyl-6-pentylpyran-4-one

C26H36O5 (428.2563)

2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),22,25-hexaene-5,21,24,25-tetrol

C26H36O5 (428.2563)

(21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),22,25-hexaene-5,21,24,25-tetrol

C26H36O5 (428.2563)

(1s,3r,4r,6r,7s,8s,9r,10r,13r,14r,16s)-4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

4,6,7,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl acetate

C22H36O8 (428.241)

7-(1-hydroxy-2-methylpropylidene)-2-(2-methoxypropan-2-yl)-5,5-bis(3-methylbut-2-en-1-yl)-1-benzofuran-4,6-dione

C26H36O5 (428.2563)

1-{6,7'-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-2h-3',11'-dioxaspiro[naphthalene-1,4'-tricyclo[7.3.0.0²,⁶]dodecane]-1',6',8'-trien-12'-yl}propan-2-one

C26H36O5 (428.2563)

(2s,3r,4s,5r)-2-({2-[(3s,3as,5r,7as)-3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl]propan-2-yl}oxy)-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)

2-({1-ethenyl-11a-methyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-6-methyloxane-3,4,5-triol

C26H36O5 (428.2563)

2-{[2-(3-acetyl-3a-hydroxy-7a-methyl-hexahydro-1h-inden-5-yl)propan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl acetate

C22H36O8 (428.241)

(3e)-4-[(2r,2'r,4'as,6'r,8'as)-4,6'-dihydroxy-6-(hydroxymethyl)-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalen]-7-yl]but-3-en-2-one

C26H36O5 (428.2563)

4-[4,6'-dihydroxy-6-(hydroxymethyl)-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[1-benzofuran-2,1'-naphthalen]-7-yl]but-3-en-2-one

C26H36O5 (428.2563)

methyl (4ar,5s,6r,8as)-5-[2-(furan-3-yl)ethyl]-5,6-dimethyl-8a-({[(2z)-2-methylbut-2-enoyl]oxy}methyl)-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate

C26H36O5 (428.2563)

(2s,3r,4r,4as,7r,8s,8as)-8-(acetyloxy)-2,4,7,8a-tetramethyl-6-oxo-hexahydropyrano[3,2-b]pyran-3-yl (4s)-4-hydroxyoctanoate

C22H36O8 (428.241)

(1r,2s,3s,4r,8r,9s,10r)-2,8,9-trihydroxy-6-oxo-4-pentyl-5,11-dioxabicyclo[8.1.0]undecan-3-yl (2e)-2,4-dimethylhex-2-enoate

C22H36O8 (428.241)

(1e,3s,3ar,5r,7r,7as)-1-ethylidene-3-[(2-methylbutanoyl)oxy]-4-methylidene-2-oxo-7-(prop-1-en-2-yl)-hexahydroinden-5-yl (2e)-3-methylpent-2-enoate

C26H36O5 (428.2563)

(1s,2r,4s,5r,6s,7s,9r)-5-hydroxy-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-en-1-yl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-4-yl acetate

C26H36O5 (428.2563)

1-[(1r,2r,4as,6r,8as,12'r)-6,7'-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-2h-3',11'-dioxaspiro[naphthalene-1,4'-tricyclo[7.3.0.0²,⁶]dodecane]-1',6',8'-trien-12'-yl]propan-2-one

C26H36O5 (428.2563)

2-[(4z,8r,10e)-5-[(acetyloxy)methyl]-11-methyl-14-oxabicyclo[11.2.1]hexadeca-1(15),4,10,13(16)-tetraen-8-yl]prop-2-en-1-yl butanoate

C26H36O5 (428.2563)

(2r,3s,4r,5r,6s)-2-{[(1r,3as,3bs,9bs,11ar)-1-ethenyl-11a-methyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-methyloxane-3,4,5-triol

C26H36O5 (428.2563)

methyl (3ar,3bs,5as,9ar,9bs,11ar)-1-hydroxy-2,3b,6,6,9a,11,11a-heptamethyl-3,7-dioxo-4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-3a-carboxylate

C26H36O5 (428.2563)

methyl (1r,2r,4as,5r,8as)-5-[2-(furan-3-yl)ethyl]-1,4a-dimethyl-2-{[(2z)-2-methylbut-2-enoyl]oxy}-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C26H36O5 (428.2563)

(1s,3r,4r,6r,7r,8s,9r,10r,13r,14r,16r)-3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)

(2e,4e)-5-[(1r,2s,4s,5as,7as,11as,11bs)-4-[(2s)-butan-2-yl]-1,5a-dihydroxy-6,9-dimethyl-5-methylidene-1h,2h,4h,7ah,8h,11h,11ah,11bh-naphtho[1,2-d]oxepin-2-yl]penta-2,4-dienoic acid

C26H36O5 (428.2563)

17-(3,5-dihydroxyphenyl)heptadecane-6-sulfonic acid

C23H40O5S (428.2596)

1-[(1r,2r,4as,6r,8as,12's)-6,7'-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-2h-3',11'-dioxaspiro[naphthalene-1,4'-tricyclo[7.3.0.0²,⁶]dodecane]-1',6',8'-trien-12'-yl]propan-2-one

C26H36O5 (428.2563)

(1r,2r,5s,6r,10r,11s,12r,15r,16r,18s,19r)-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-ene-11,16,18-triol

C26H36O5 (428.2563)

(1e)-2-[(1r,7r,8s,11r,15s)-1-methoxy-4,8,12,12-tetramethyl-3,13-dioxatetracyclo[6.6.2.0²,⁶.0¹¹,¹⁵]hexadeca-2(6),4-dien-7-yl]ethenyl 3-methylbut-2-enoate

C26H36O5 (428.2563)

(1s,2s,5s,6r,7r,10r,11s)-6-[(2,5-dihydroxyphenyl)methyl]-5-hydroxy-5,7,11-trimethyl-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-12-one

C26H36O5 (428.2563)

(2e,4e)-5-[(1s,2s,6r,7r,9r,10s,11s,12r,17r)-10-hydroxy-2,6,15,19-tetramethyl-3,8-dioxatetracyclo[9.8.0.0²,⁷.0¹²,¹⁷]nonadeca-14,18-dien-9-yl]penta-2,4-dienoic acid

C26H36O5 (428.2563)

2-[(2s,4s)-4-(6-ethyl-3,5-dimethyl-4-oxopyran-2-yl)-3-oxopentan-2-yl]-3,5-dimethyl-6-pentylpyran-4-one

C26H36O5 (428.2563)

(5s,6r,8s,8ar)-5-{2-[(2s,4s,5r)-3,4-dihydroxy-2,5-dimethoxyoxolan-3-yl]ethyl}-8-hydroxy-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid

C22H36O8 (428.241)

(4bs,6as,10as,10bs)-3-(2-carboxyethyl)-2-(carboxymethyl)-4b,7,7,10a-tetramethyl-4ah,5h,6h,6ah,8h,9h,10h,10bh,11h,12h-naphtho[2,1-f]isoquinolin-4a-yl

C26H38NO4 (428.2801)

5-[2-(furan-3-yl)ethyl]-1,4a,6-trimethyl-3-[(3-methylpent-2-enoyl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid

C26H36O5 (428.2563)

3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl acetate

C22H36O8 (428.241)

methyl (1e)-6-[2-(furan-3-yl)-2-[(2-methylbutanoyl)oxy]ethyl]-6,7-dimethyl-10-methylidenecyclodeca-1,3-diene-1-carboxylate

C26H36O5 (428.2563)

2-[(1s,2r,5r,7r,8s,11s,12r)-7-(acetyloxy)-2,8,11-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)

2-[(1s,2r,5r,7r,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoic acid

C22H36O8 (428.241)

[(4z,8r,10e)-8-[3-(acetyloxy)prop-1-en-2-yl]-11-methyl-14-oxabicyclo[11.2.1]hexadeca-1(15),4,10,13(16)-tetraen-5-yl]methyl butanoate

C26H36O5 (428.2563)

ethyl 2-{5-[2-({2-[5-(2-hydroxypropyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoate

C23H40O7 (428.2774)

6-[(2,5-dihydroxyphenyl)methyl]-5-hydroxy-5,7,11-trimethyl-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-12-one

C26H36O5 (428.2563)

{8-[3-(acetyloxy)prop-1-en-2-yl]-11-methyl-14-oxabicyclo[11.2.1]hexadeca-1(15),4,10,13(16)-tetraen-5-yl}methyl butanoate

C26H36O5 (428.2563)

(3e)-4-[(1's,2s,3s,3'r,5r,7'r,9'e,11'r)-10'-(hydroxymethyl)-3,3',14'-trimethyl-12'-oxospiro[oxolane-2,6'-tricyclo[9.3.0.0³,⁷]tetradecane]-9',13'-dien-5-yl]-3-methylbut-3-enoic acid

C26H36O5 (428.2563)

(1s,2s,5s,6s,7s,10r,11s)-6-[(2,5-dihydroxyphenyl)methyl]-5-hydroxy-5,7,11-trimethyl-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-12-one

C26H36O5 (428.2563)

(2e,4e,6e)-7-[(1s,2r,4ar,8ar)-2-[(2s,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-2-hydroxy-6-(hydroxymethyl)-3-methyl-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid

C26H36O5 (428.2563)